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Axl is a receptor tyrosine kinase that contains both
immunoglobulin and fibronectin III repeats in its extra-
cellular domain reminiscent of cell adhesion molecules.
Expression of the receptor tyrosine kinase Axl in the
32D myeloid cell line permits aggregation of cells in
response to treatment with the native ligand GAS6; this
aggregation was not observed in untreated 32D-Axl cells
nor in treated parental cells. This aggregation can be
blocked by the addition of excess Axl extracellular do-
main peptide and does not require intracellular Axl ki-
nase activity. Cell surface binding activity of GAS6 was
mapped to distinct plasma membrane interacting do-
mains that are separate from the GAS6 motifs that en-
gage the Axl receptor. This suggests that aggregation is
mediated by a heterotypic intercellular mechanism
whereby cell-bound GAS6 interacts with Axl receptor on
an adjacent cell. This mechanism is supported by our
observation that GAS6 binds to 32D parental cells which
then permits their aggregation with untreated 32D-Axl
cells. We have recently demonstrated that the GAS6-Axl
interaction does not initiate mitogenesis in 32D cells.
When considered with the adhesion results, these data
suggest that an important biological function of the Axl-
GAS6 interaction is to mediate cell-cell binding.
Cell adhesion molecules mediate the maintenance of tissue
structures in adult organisms and morphogenesis in develop-
ing embryos. For example, E-cadherin is necessary for tight
association in adult epithelium and is involved in the compac-
tion of mesenchymal cells into a polarized epithelium (1). In
addition to providing the physical means for cell assembly,
these adhesion molecules also function, in part, to transduce
signals from extracellular components such as the (2). Al-
though structurally diverse, many cell adhesion molecules ex-
hibit similarities to the immunoglobulins (Igs) and thus have
been classified in the Ig superfamily of genes. Specifically, a
general arrangement involving Ig motifs in the NH2 terminus
followed by fibronectin III domains in the COOH terminus of
the extracellular region characterizes a subgroup of these ad-
hesion molecules (1, 2). Included in this group are molecules
such as the neural cell adhesion molecule, which is involved in
the proper migration of neural crest cells, and protein phos-
phatase-k and -m, which possess intrinsic enzymatic function.
We have previously identified a novel transforming receptor
tyrosine kinase, Axl (3), which contains a similar organization
of Ig and fibronectin III motifs in its extracellular domain
(ECD).1 Since the original description of Axl, several other
related genes with transforming potential (Sky and Mer) have
been cloned (4, 5). All members of this Axl family of receptor
tyrosine kinases harbor a similar ECD architecture, raising the
possibility that Axl and its relatives may function in cell adhe-
sion. That Axl may be a cell adhesion receptor was suggested by
experiments using the murine Axl homolog, Ark. S2 insect cells
overexpressing Ark formed multicellular aggregates that could
be blocked by excess recombinant Ark ECD (6). Similar results
could be achieved upon overexpression of D-Trk or protein phos-
phatase-k and -m in the same S2 cells (7–9). These data raise
the possibility that receptor tyrosine kinases and transmem-
brane phosphatases may function both as adhesion molecules
and as elements of the signaling cascade.
A ligand for Axl has been characterized by its ability to
induce Axl autophosphorylation, directly bind the receptor, and
cause receptor down-regulation (10). This polypeptide is the
product of the growth arrest-specific gene 6 (GAS6) and was
originally cloned from serum-starved NIH 3T3 cells (11). GAS6
is composed of several structural motifs including a Gla do-
main, EGF repeats, and G domains. The G domains, which
have homology to the steroid hormone-binding globular pro-
tein, are sufficient to induce autophosphorylation of both the
Axl and Rse receptors (12). The Gla domain of GAS6 is thought
to bind to negatively charged phospholipids, whereas the EGF
repeats can interact with integral membrane proteins; both
interactions are dependent upon extracellular calcium (13, 14).
GAS6 contains sites for b-hydroxylation of Asp and Asn which
can also mediate protein-protein interactions (15). As Axl is a
transforming receptor tyrosine kinase it was initially antici-
pated that its ligand, GAS6, would be a potent growth factor for
Axl-expressing cells. However, although GAS6 acts as a weak
mitogen in 3T3 cells (16) it is not mitogenic in other Axl-
expressing cell lines. Moreover, exposure of 32D cells with
ectopic expression of the Axl receptor to soluble recombinant
GAS6 does not appear to induce intracellular proliferation sig-
nals (17). Thus, despite the fact that GAS6 acts as a ligand for
Axl, the primary biological function of this interaction remains
unclear.
The homotypic aggregation of Ark-expressing S2 cells led us
to explore the possible contribution of GAS6 to the adhesive
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function of Axl in mammalian cells. We employed the murine
myeloid cell line 32D as a model system to study these effects
because, like S2, 32D cells grow in suspension as separate cells.
Furthermore, we have shown that 32D cells overexpressing Axl
have no mitogenic response to GAS6 treatment and therefore
will permit the investigation of nonproliferative GAS6 effects
(17). Our work described herein indicates that, unlike insect
cells, 32D cells do not form aggregates when Axl is overex-
pressed. However, GAS6 dramatically induces Axl-mediated
cellular aggregation, suggesting that a major role for the Axl-
GAS6 interaction is in cell adhesion.
EXPERIMENTAL PROCEDURES
Aggregation Assays—Cells were resuspended in growth medium sup-
plemented with GAS6 and seeded in four consecutive wells of a 24-well
plates in a total of 1 ml of medium. Each experiment was repeated three
times. Cellular aggregates of at least 200 mm in diameter (the diameter
of a single 32D cell is 5 mm) were counted in a single “field of view” using
an Olympus model CK 2 microscope at a magnification of 340 with a
10-mm ruler in the eyepiece calibrated with a stage micrometer (Olym-
pus). Five separate fields of view were counted per sample, and the
results were averaged. Inhibition assays were conducted by mixing
Axl-ECD with GAS6 at a 20:1 or 2:1 molar ratio and incubating this
mixture at 37 °C for 30 min before the addition of cells. Bovine serum
albumin was purchased from Sigma. Recombinant GAS6 was isolated
from transfected Chinese hamster ovary cells grown in medium sup-
plemented with vitamin K as described previously (10). Protein S was
purchased from Hematologic Technologies (Essex Junction, VT).
Cell Culture and Cell Lines—Both the 32D-EAK and 32D-Axl cell
lines were maintained as described previously (18). Briefly, 32D growth
medium includes an exogenous source of interleukin-3 which is sup-
plied by Wee-Hi conditioned medium. Introduction of expression con-
structs was achieved by infection with recombinant retrovirus in the
pLXSN or pLXSP (gift of Dr. John Olson; UNC-Chapel Hill) vector in a
manner similar to that of 32D-EAK and 32D-Axl as described previ-
ously (18). Briefly, an ecotropic packaging cell line (GP1E86) was
transfected by the addition of DNA and LipofectAMINE (Life Technol-
ogies, Inc.) and selected with G418 (Life Technologies, Inc.) or 1 mg/ml
puromycin (Calbiochem). Retrovirus was harvested from stable cell
lines and used to infect 32D cells followed by overnight passage and
subsequent selection with either G418 at 500 ng/ml or puromycin at 1
mg/ml.
Recombinant Constructs—The Axl lysine to arginine (32D-Axl
K567R) construct was made by cutting the previously described Axl
SalI pLXSN vector with SalI and XhoI and ligating this to an insert
carrying the K567R cytosolic domain derived from the previously de-
scribed EAK K567R construct by an XhoI and SalI digest (18, 19).
Positive clones were screened by restriction digests and junctions con-
firmed by sequencing. The Axl receptor devoid of cytosolic domains
(Axl-ECD-TM) was made by digesting the Axl SalI pLXSN vector with
SalI and XhoI and subsequent ligation of the vector. This creates a
truncated Axl gene whose coding sequence stops at 1578 located at the
stop insert sequence on the cytosolic side of the transmembrane
domain.
Construction of an HA-tagged GAS6 construct was achieved by ap-
pending HA to the 39 end of GAS6. To achieve this, a KpnI site was
introduced to the 39 end of GAS6 by polymerase chain reaction ampli-
fication using the pGAS-3 and 39GAS6-HA oligonucleotides. The se-
quence of pGAS-3 in 59-CGAATGCAGCCAGGCCA-39 and that of
39GAS6-HA is 59-CGGGGTACCCGGCTGCGGCGGGCTCCACGG-39.
Following polymerase chain reaction the amplicon was digested with
BglII and KpnI and inserted into the pBS HA (gift of Yue Xiong;
UNC-Chapel Hill) vector that had similarly been cut with BglII and
KpnI restriction enzymes. Clones were selected, and the 39GAS6 seg-
ment was shuttled into the pSVSPORT vector. This vector was re-
stricted with HindIII, EcoRI linkers were added, and the construct was
subsequently subcloned into pLXSP.
Production of Axl-ECD—The Axl-ECD was made by purifying hexa-
histidine-tagged Axl-ECD from baculovirus-infected Sf9 cells. Briefly,
Sf9 cells (1 3 106 cells/ml with viability greater than 90%) were infected
with high titer virus stock and allowed to proceed 5 days until viability
was less than 40%. Cells were harvested by centrifugation and cells
lysed with Sf9 lysis buffer (1% Nonidet P-40, 300 mM NaCl, 50 mM
Na2HPO4, 10 mg/ml leupeptin, 10 mg/ml aprotinin, and 20 mg/ml phen-
ylmethylsulfonyl fluoride). Lysates were then passed over a Ni21-NTA
slurry (Qiagen) which was washed with 6 M guanidinium HCl, 0.2 M
acetic acid, and subsequently equilibrated with 10 mM Na2HPO4, pH
7.0, 150 mM NaCl. Bound protein was eluted with 100 mM imidazole and
eluate dialyzed to purify protein.
FACS and Western Analysis—An Axl monoclonal antibody directed
against the first Ig Loop of Axl (amino acids 33–139) was directly
conjugated to phycoerythrin and used to assay Axl surface expression in
a Becton Dickinson FACSCAN. Briefly, 800 ng of Axl-phycoerythrin
monoclonal antibody was mixed with 1 3 106 cells at 1 3 107 cells/ml
and incubated for 20 min on ice. Stained cells were then washed two
times with phosphate-buffered saline, 0.1% bovine serum albumin and
resuspended at 1 3 106 cells/ml. The reported value represents the
mode of fluorescent intensity determined using the flow cytometry
software operating package Cyclopes. Surface expression of GAS6 was
analyzed with anti-GAS6 antibody at 170 ng/1 3 106 cells followed by
immunofluorescence with goat anti-rabbit fluorescent isothiocyanate at
800 ng (Chemicon). Western analysis was conducted on 50 mg of cell
lysate using the previously described Axl polyclonal antibodies (18) for
Axl expression or phosphotyrosine antibodies for Axl autophosphoryla-
tion (Upstate Biotechnology Inc.). Immunoblot analysis for HA-GAS6
was conducted with HA 12-CA5 antibody (Boehringer Mannheim) at 1
mg/ml followed by a goat anti-mouse horseradish peroxidase antibody
with the ECL detection system (Amersham Corp.).
Fluorescent Tagging of 32D Cells and Immunofluorescent Micros-
copy—32D or 32D-GAS6-HA cells were incubated with CellTracker
Orange (purchased from Molecular Probes, Eugene, OR) at 0.5 mM for
30 min; 32D-Axl or 32D-Axl-GAS6-HA cells were incubated with Cell-
Tracker Green at 10 mM for 30 min (purchased from Molecular Probes).
After staining, cells were washed extensively with RPMI and then
returned to tissue culture. Green fluorescence was visualized with a
band pass filter at 510–560 nM (Nikon Cube G2-A); red fluorescence
was analyzed with a band pass filter of 470–490 nM (Nikon Cube B1-E).
Unbound GAS6 was washed from cells by a 2-fold resuspension in
growth medium and centrifugation. To ensure complete removal of
unbound GAS6 the conditioned medium from the ligand-treated and
washed cells was assayed for the ability to induce receptor down-
regulation of 32D-Axl cells. Two washes were sufficient to remove all
unbound GAS6 as assayed by the receptor down-regulation assay (data
not shown).
Truncated GAS6 Protein—The deletion of GAS6 truncates sequences
amino-terminal to amino acid 279. Conditioned medium from embry-
onic kidney 293 cells transfected with either empty vector or truncated
GAS6 was used as a source of ligand.
RESULTS
GAS6 Induces Cell-to-cell Homotypic Binding of 32D-Axl
Cells—The murine myeloid precursor cell line 32D grows as
single discrete suspension cells in culture, and 32D-Axl cells
exhibit the same growth characteristics as 32D parental cells.
Passage of 32D-Axl cells, but not 32D parental cells, in GAS6-
supplemented growth medium induces the formation of large
cellular aggregates (Fig. 1C). Individual aggregates of 200 mm
FIG. 1. GAS6 induces cellular aggregation of 32D-Axl but not
32D-Parental cells. 32D-Axl cells were treated with GAS6 (220 ng/ml)
for 40 h. A picture of the culture was made with a magnification of 3 40.
Panel A, 32D-Parental cells treated with GAS6. Panel B, 32D-Axl cells,
untreated. Panel C, 32D-Axl cells treated with GAS6. Panel D, 32D-
Axl-GAS6-HA compound cell line, untreated.
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in diameter can be observed as early as 14 h of GAS6 treatment
(220 ng/ml) and increase in number as a function of time (Fig.
2). Furthermore, after 40 h of ligand treatment large superag-
gregates (1.5 mm in diameter) can be detected. At this time
point, there is a notable absence of single cells in cultures
treated with GAS6 (220 ng/ml for 40 h) with approximately
90% of the cells contained in aggregates (data not shown).
Cellular aggregation can be blocked by 90% when soluble Axl-
ECD is added in a 20:1 molar ratio of Axl-ECD to ligand and
partially blocked (20% blocking) with a 2:1 molar ratio (Fig. 3).
That the Axl-ECD effect is specific is supported by the fact that
bovine serum albumin was not able to block aggregation when
mixed with GAS6 at concentrations similar to that of Axl-ECD.
Aggregation is dependent upon the concentration of both ligand
and cells, which is consistent with a stoichiometric and satu-
rable process (Fig. 4). This cell-to-cell binding is also blocked by
the addition of calcium chelators (5 mM EGTA) as expected for
a Gla protein (data not shown). Thus, GAS6 induces aggrega-
tion that is specific to Axl-expressing 32D cells and which is
dependent on the duration of GAS6 treatment as well as con-
centration of cells and ligand.
It is possible that the GAS6-induced aggregation of 32D-Axl
cells is the result of a contaminant from the isolation of recom-
binant GAS6. To rule out this possibility, we determined the
aggregation profile of a 32D cell line expressing both GAS6 and
Axl. An HA-tagged GAS6 recombinant retrovirus was used to
infect the 32D parental (to generate 32D-GAS6-HA) and 32D-
Axl (to generate 32D-Axl-GAS6-HA) cell lines, and expression
of both Axl and GAS6-HA was determined by immunoblot
analysis (Fig. 5, A–C). Furthermore, the GAS6-HA recombi-
nant protein secreted from these cells is capable of stimulating
Axl autophosphorylation, indicating the functional integrity of
this protein (Fig. 5D). The 32D-Axl-GAS6-HA compound cell
FIG. 2. Cellular aggregates increase as a function of time. 32D-
Axl, but not 32D-Axl-GAS6, cells were treated with GAS6 (220 ng/ml)
and the formation of aggregates monitored as a function of time. Each
culture was counted with five separate fields of view, each culture was
seeded four different times/experiment, and each experiment was re-
peated three times. Reported counts are an average of all measure-
ments. Means 6 S.E. of four experiments performed in duplicate are
shown. f, untreated; Œ, GAS6-treated; M, 32D-Axl-GAS6-HA.
FIG. 3. GAS6-induced clumping of 32D-Axl cells is inhibited by
Axl-ECD. Cells were seeded at 5 3 105 cells/ml and treated with GAS6
(70 ng/ml) for 40 h in the presence of Axl-ECD. A 1:2 molar ratio of
GAS6:Axl-ECD inhibits the clumping by 20%, and a 1:20 ratio inhibits
the clumping by 90%. Means 6 S.E. of four experiments performed in
duplicate are shown.
FIG. 4. Cell and ligand concentration mediate degree of cellu-
lar aggregation. 32D-Axl cells express the wild-type receptor, 32D-Axl
K567R cells express a kinase-dead mutant, and the 32D-Axl-ECD cells
express an Axl construct devoid of the cytosolic domain. Panel A, ligand
concentration determines degree of aggregation. Cells were seeded at
5 3 105 cells/ml and treated with GAS6 for 40 h. f, 32D-Axl; Œ, 32D-Axl
K567R; l, 32D-Axl-ECD; E, 32D-Parental. Panel B, cell concentration
determines degree of aggregation. Cultures were treated with 220
ng/ml GAS6 for 40 h. Means 6 S.E. of five experiments performed in
triplicate are shown. f, 32D-Axl; l, 32D-Axl K567R; Œ, 32D-Axl-ECD.
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line exhibited marked aggregation (Fig. 2) and did not respond
further to the exogenous addition of GAS6 (data not shown). In
contrast, the 32D-GAS6-HA cell line did not form aggregates.
Taken together, these results indicate that GAS6 specifically
induces homotypic binding of 32D-Axl cells.
Protein S has a high degree of similarity to GAS6 and,
therefore, may be able to induce cellular aggregation in 32D-
Axl cells. To test this possibility, 32D-Axl cells were treated
with protein S at concentrations comparable to those used for
GAS6-induced aggregation (220 and 40 ng/ml). Protein S was
not able to mimic the action of GAS6 on cell aggregation at
these concentrations (data not shown). This is consistent with
previous studies showing that protein S does not bind to Axl in
in vitro assays (19).
The Kinase Domain of Axl Is Not Required for Aggrega-
tion—We have shown previously that treatment of 32D cells
expressing an EGF receptor-Axl chimeric receptor tyrosine ki-
nase (32D-EAK) with the foster ligand EGF will result in
kinase activation and cellular proliferation (18). However,
treatment of 32D-EAK cells with EGF does not result in cell
aggregates, suggesting that the Axl-mediated aggregation is
independent of the kinase activity (data not shown). To confirm
this possibility, we investigated a panel of Axl kinase mutants
for their ability to mediate binding. The mutants include a
“kinase-dead” Axl whereby the conserved lysine in the ATP
binding site was mutated to arginine (32D-Axl K567R) thus
inactivating the enzymatic activity of the kinase. Another mu-
tant containing the ECD and plasma membrane-spanning re-
gion of the receptor (32D-Axl-ECD) was created by inserting a
stop codon at the stop insertion sequence at amino acid 529.
Correct size and function of the mutants were confirmed by
immunoblot analysis, which showed that the 32D-Axl K567R
clone had an Axl antibody-specific band that migrated at 140
kDa and which did not exhibit autophosphorylation in response
to GAS6 treatment (Fig. 6, A and B), whereas the 32D-Axl-ECD
clone expressed the expected 89-kDa protein that cross-reacted
with the amino-terminal Axl antibody (Fig. 6C). Surface ex-
FIG. 5. Expression and function of GAS6-HA in 32D cells. 32D
cells were infected with a virus carrying a fusion gene of GAS6 with the
epitope HA antigen. Panel A, conditioned media from various 32D
subclones (including 32D-GAS6-HA or 32D-Axl-GAS6-HA cells) was
treated with an HA antibody to immunoprecipitate HA-GAS6. The
immunoprecipitates were then subjected to Western analysis with the
same HA antibody. Panel B, cell lysates from the same clones as above
were subjected to Western analysis with the HA antibody to determine
cellular levels of GAS6. Panel C, expression of Axl in the same set of
32D subclones was confirmed by Western analysis with an Axl anti-
body. Panel D, only conditioned medium from 32D-GAS6-HA cells was
able to induce Axl phosphorylation in 32D-Axl cells.
FIG. 6. Expression of the Axl K567R and Axl-ECD constructs in
32D cells. 32D-Axl K567R cells express a kinase-dead mutant, and the
32D-Axl-ECD cells express a construct devoid of the cytosolic domain.
Expression level of Axl in 32D-Parental, 32D-Axl, 32D-Axl-K567R, and
32D-Axl ECD cells was assayed by Western analysis using an Axl
antibody. Panel A, Western analysis using the Axl antibody shows that
AXL is expressed in either 32D-Axl or 32D-Axl K567R cells regardless
of ligand treatment (GAS6, 220 ng/ml for 10 min). Panel B, the same set
of lysates were immunoprecipated with Axl antibody and subjected to
Western analysis with a phosphotyrosine antibody, which shows that
cells harboring the Axl K567R mutant, in contrast to 32D-Axl cells, are
not able to activate Axl phosphorylation in response to GAS6 treatment.
Panel C, Western analysis with Axl antibody of either 32D-Parental,
32D-Axl, or 32D-Axl-ECD clones showing the expected sizes for either
wild-type p140 Axl or its truncated counterpart p89 Axl-ECD.
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pression of mutants was confirmed by FACS analysis, which
showed that both the 32D-Axl K567R and the 32D-Axl-ECD
cultures contain about half the amount of surface receptor as
did the 32D-Axl cultures (data not shown). However, when
tested for their ability to induce cellular aggregation in re-
sponse to GAS6, both 32D-Axl K567R and 32D-Axl-ECD clones
were capable of mediating cellular aggregation at a level equal
to that of 32D-Axl cells (Fig. 4). Furthermore, the kinetics of
aggregation for the two mutant receptors closely matched that
of the wild-type Axl receptor. Thus, the ability of GAS6 to
induce homotypic binding is mediated solely by the transmem-
brane and extracellular domains of Axl and is independent of
the kinase function.
GAS6 Binds to 32D Cells and Renders Them Capable of
Binding to 32D-Axl Cells—One mechanism to bring about ag-
gregation includes the binding of GAS6 to the surface of one cell
and simultaneous interaction with Axl receptor on an adjacent
cell. To investigate this possibility we treated 32D cells with
GAS6 (220 ng/ml) and analyzed the amount of GAS6 which was
cell surface-bound. Surface-bound GAS6 protein was measured
by flow cytometric analysis of cells labeled with a rabbit anti-
GAS6 antibody followed by goat anti-rabbit fluorescein isothio-
cyanate and could be observed as early as 30 min (Fig. 7) after
the addition of GAS6 and as late as 27 h (data not shown),
indicating that GAS6 remains bound during the time required
to form aggregates. Cell surface binding was shown to be de-
pendent on divalent cations as 5 mM EGTA blocked surface
display of GAS6 (data not shown). This indicates that surface
binding of GAS6 may be an important component of aggrega-
tion mechanics. In support of this is the enhanced aggregation
observed in a 32D-Axl-GAS6-HA cell line that has high levels of
Axl expression and also expressed GAS6 that was primarily
membrane-bound.2 This indicates that surface-bound GAS6
can be a primary determinant in mediating adhesion of Axl-
expressing cells.
We mapped the motifs in GAS6 which mediate adhesion by
treating 32D-Axl cells with a truncated form of GAS6. The
deletion is amino-terminal to the first G domain (Fig. 8A) and
deletes the EGF-like repeats as well as the Gla domain at
amino acid 279, leaving only the two G domains. Treatment of
32D-Axl cells with medium containing the truncated GAS6
ligand did not mediate aggregation (Fig. 8B) despite its ability
to induce phosphorylation of the Axl receptor.3 This study
indicates that either the Gla domain and/or the EGF motifs are
necessary for GAS6-mediated aggregation of 32D-Axl cells.
If GAS6 binds to the surface of 32D cells, then, in our pro-
posed model, 32D-Axl cells should be able to form mixed cell
aggregates with GAS6-bound 32D cells. To test this possibility
we treated 32D-GAS6-HA cells with a rhodamine-labeled fluo-
rescent dye (CellTracker Orange). This lipophilic label
traverses the cell membrane and is cleaved by intracellular
proteases, which results in the covalent binding of the label to
intracellular constituents. This permits the tracking of a
unique population of cells by the assessment of red fluores-
cence. 32D-Axl cells were treated similarly with eosin diacetate
(CellTracker Green), which labels cells green. When these two
populations were cocultured, we found that 100% of the aggre-
gates contained both cell populations (Fig. 9 and Table I). As
before, the coincubation of 32D with 32D-Axl or 32D-GAS6-HA
cells did not induce cell aggregates. These data support the
notion that Axl and GAS6 induce cell adhesion through a
heterotypic intercellular mechanism. 32D-GAS6-HA cells ex-
press high levels of surface GAS6 which may potentially alter
membrane charge characteristics to support mixed cell aggre-
gation. To assess this possibility, we incubated 32D parental
cells with GAS6 for 30 min followed by washing of unbound
ligand. This results in a significantly lower amount of surface
bound GAS6 than when the GAS6 cDNA is transfected into
32D cells. These cells were cocultured with 32D-Axl cells and
were found to induce 100% mixed aggregates, suggesting that
2 Y. W. Fridell, unpublished results. 3 B. Varnum, unpublished results.
FIG. 7. GAS6 binds to the surface of 32D cells. 32D cells were
either untreated or treated with GAS6 (220 ng/ml) for 30 min. The
amount of surface-bound GAS6 was assayed by staining cells with a
rabbit anti-GAS6 antibody and labeled with a fluorescein isothiocya-
nate goat anti-rabbit antibody. Panel A is the fluorescent intensity of
untreated cells; panel B shows the intensity of GAS6-treated cells.
FIG. 8. Truncated GAS6 does not mediate aggregation. Panel A,
structure of GAS6 and the amino-terminal deletion mutant at amino
acid 279 which retains Axl binding activity. Panel B, 32D-Axl cells were
treated with full-length GAS6 or amino-terminal truncated GAS6 and
the aggregation profile characterized. Light column, untreated; striped
column, GAS6DN; dark column, GAS6.
Axl Mediates Cell Adhesion in Response to GAS6 23289
the GAS6-Axl interaction is not dependent on high levels of
local GAS6 expression.
To eliminate the possibility that GAS6 induces aggregation
only of 32D-Axl cells and that the formation of mixed aggre-
gates is the result of nonspecific recruitment during the adhe-
sion process, untreated 32D parental cells were coincubated
with 32D-Axl cells that were pretreated with exogenous GAS6.
The predicted interaction should be between pretreated 32D-
Axl cells only and would exclude the untreated 32D parental
cells. The proportion of mixed cell aggregates would be there-
fore a measure of background aggregation. In this experiment,
only 26% of the cellular aggregates were of a mixed cell type
compared with 100% in all other combinations. Therefore, our
data confirm that membrane-bound GAS6 is able to mediate
heterotypic interactions with Axl-expressing cells.
DISCUSSION
GAS6 has several structural motifs, which suggests that this
polypeptide can participate in combinatorial interactions (11,
12). Consistent with this prediction we have provided evidence
that GAS6 has at least two distinct functions. We have shown
that GAS6 binding to the cell surface is dependent on the Gla
and EGF domains in the presence of Ca21, whereas the Axl
activation activity is dependent only on the steroid hormone
binding domains (G domains). This is consistent with the ob-
servation that the Gla domain of protein S, a GAS6 homolog,
interacts with negatively charged phospholipids, and the EGF
repeats interact with integral membrane proteins in a calcium-
dependent fashion (14, 15). Thus, these domains may permit
targeting of GAS6 to the plasma membrane while the G do-
mains interact directly with Axl receptor. As the kinase activity
of Axl is dispensable for this interaction it appears that Axl-
mediated aggregation does not require interaction of down-
stream signaling pathways. This contrasts with suggestions of
earlier reports where high levels of Axl expression in insect
cells induced cellular aggregation that correlated with a slight
increase in the level of Axl phosphorylation (6). Nevertheless,
when taken together, our data indicate that one biological
outcome of the GAS6-Axl interaction is to bring cells into close
apposition.
Stimulation of endogenous Axl with the native ligand does
not result in a growth response except in a limited number of
cell lines (17). This brings into question whether the primary
function of Axl is mitogenic. That proliferative responses may
be a limited aspect of receptor tyrosine kinase signaling is best
demonstrated by the ability of the Eph family to mediate fas-
ciculation and collapse of axons of the retinal ganglion to the
optic tectum but not mitogenesis. In this manner, the ligand-
receptor interaction regulates a structural determinant such as
topographical targeting of axons (20). Thus, failure of GAS6 to
drive proliferation of Axl-expressing cells supports the notion
that a physiologic role of this ligand receptor interaction may
involve nonmitogenic processes.
Previous studies of Axl expression in hematopoiesis have
shown that Axl is expressed predominantly in the bone marrow
stroma, and increased expression is observed upon stimulation
of peripheral blood with phorbol esters or interferon-a (21). In
addition, phenotypic analysis of bone marrow-derived cells
shows that mature monocytes (CD141) express Axl.4 Several
investigations have shown that interferon-a treatment of
monocytes leads to increased adhesion, suggesting that Axl
may participate as a cell adhesion receptor in activated mono-
cytes (22–24). In development, Axl is expressed in mesenchy-
mal cells during organogenesis,5 raising the possibility that
coordinated expression of Axl and GAS6 may also regulate
some aspects of cell migration during embryogenesis. Taken
together, our observations suggest that a potentially important
role of the Axl-GAS6 interaction is in cell adhesion, particularly
when involved with hematopoiesis and development.
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